Matches in Wikidata for { <http://www.wikidata.org/entity/Q90582877> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q90582877 description "artículu científicu espublizáu en payares de 2018" @default.
- Q90582877 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90582877 description "scientific article published on 19 November 2018" @default.
- Q90582877 description "wetenschappelijk artikel" @default.
- Q90582877 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q90582877 description "գիտական հոդված հրատարակված 2018 թվականի նոյեմբերի 19-ին" @default.
- Q90582877 name "Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks" @default.
- Q90582877 name "Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks" @default.
- Q90582877 type Item @default.
- Q90582877 label "Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks" @default.
- Q90582877 label "Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks" @default.
- Q90582877 prefLabel "Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks" @default.
- Q90582877 prefLabel "Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks" @default.
- Q90582877 P1433 Q90582877-078124D3-C1D7-4131-9201-40560C5D6111 @default.
- Q90582877 P1476 Q90582877-E4C9075C-E1C3-41CD-AE68-8347B0599DAE @default.
- Q90582877 P2093 Q90582877-0224E553-28D3-4F4B-AD1F-852119FD0928 @default.
- Q90582877 P2093 Q90582877-0AC18B6B-7C04-4062-A361-24C1AF0E3172 @default.
- Q90582877 P2093 Q90582877-12A02AC9-9756-435C-8048-E11D4F1C112F @default.
- Q90582877 P2093 Q90582877-46FF0D90-580C-4D22-96AF-2795EBB0370A @default.
- Q90582877 P2093 Q90582877-56E2E384-89CF-4897-B70B-E1A143368724 @default.
- Q90582877 P2093 Q90582877-59F7D8BC-8CD6-40D7-A4D0-8AA4629681F6 @default.
- Q90582877 P2093 Q90582877-CC70B5AE-AD1D-460E-A340-CF475A780831 @default.
- Q90582877 P2093 Q90582877-CCCC8D0E-2AC0-4AC4-809A-7FCA9E963EFA @default.
- Q90582877 P304 Q90582877-1FA61879-1B98-431C-8468-A7A0F27D259F @default.
- Q90582877 P31 Q90582877-E4588054-5D70-478B-BA72-E3B71ED7408C @default.
- Q90582877 P433 Q90582877-EC83A05D-452C-4BAB-90A4-CA0D1903A691 @default.
- Q90582877 P478 Q90582877-98C96A29-1E85-46A9-A690-0AEFBD8E256E @default.
- Q90582877 P50 Q90582877-52065D39-2CCD-4DE0-90CC-2F9BE84A9098 @default.
- Q90582877 P577 Q90582877-B5B01397-E0E4-496F-B7BA-5A7D6175E526 @default.
- Q90582877 P698 Q90582877-6EF90746-44FB-4F0F-9ECD-E373A4920B68 @default.
- Q90582877 P921 Q90582877-8fa5e4f6-48d9-0a70-56e4-116546cfa567 @default.
- Q90582877 P921 Q90582877-A24D8006-2CB0-4EA7-BA02-E1D0C4CB70B3 @default.
- Q90582877 P698 30557128 @default.
- Q90582877 P1433 Q15759225 @default.
- Q90582877 P1476 "Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks" @default.
- Q90582877 P2093 "Chen-Yen Lin" @default.
- Q90582877 P2093 "Cheng-Chung Wei" @default.
- Q90582877 P2093 "David H Adams" @default.
- Q90582877 P2093 "Helena Marzo-Ortega" @default.
- Q90582877 P2093 "Julie Birt" @default.
- Q90582877 P2093 "Olivier Benichou" @default.
- Q90582877 P2093 "Peter Nash" @default.
- Q90582877 P2093 "Ronald Vender" @default.
- Q90582877 P304 "566-574" @default.
- Q90582877 P31 Q13442814 @default.
- Q90582877 P433 "4" @default.
- Q90582877 P478 "37" @default.
- Q90582877 P50 Q93106996 @default.
- Q90582877 P577 "2018-11-19T00:00:00Z" @default.
- Q90582877 P698 "30557128" @default.
- Q90582877 P921 Q13574436 @default.
- Q90582877 P921 Q511097 @default.